Archaeosome Adjuvant Overcomes Tolerance to Tumor-Associated Melanoma Antigens Inducing Protective CD8+ T Cell Responses
Vesicles comprised of the ether glycerolipids of the archaeon Methanobrevibacter smithii (archaeosomes) are potent adjuvants for evoking CD8+ T cell responses. We therefore explored the ability of archaeosomes to overcome immunologic tolerance to self-antigens. Priming and boosting of mice with arch...
Saved in:
| Main Authors: | Lakshmi Krishnan, Lise Deschatelets, Felicity C. Stark, Komal Gurnani, G. Dennis Sprott |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2010/578432 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sulfated lactosyl archaeol (SLA) archaeosomes as a vaccine adjuvant
by: Bassel Akache, et al.
Published: (2024-12-01) -
Targeting metabolic reprogramming to overcome immune tolerance in melanoma immunotherapy
by: Qinchen Wang, et al.
Published: (2025-06-01) -
Adjuvant Therapy: Melanoma
by: Diwakar Davar, et al.
Published: (2011-01-01) -
An update on adjuvant systemic therapies in melanoma
by: Evangeline Samuel, et al.
Published: (2019-11-01) -
Tandem CAR T-cells targeting CD19 and NKG2DL can overcome CD19 antigen escape in B-ALL
by: Jennifer Bolsée, et al.
Published: (2025-05-01)